NUS and Harvard scientists develop novel drug that could potentially treat liver cancer more effectively
(WorldNews Health)

Peptide drug FFW shows promise in reducing tumour growth and slowing down spread of cancer cells A research team led by scientists from the Cancer Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has developed a novel peptide drug called FFW that could potentially stop the development of hepatocellular carcinoma (HCC) or primary liver cancer. This landmark discovery opens door for more effective treatment of liver cancer with less side effects. Professor Daniel Tenen (right) and Dr Liu Bee Hui (left), who are researchers from CSI Singapore, are members of the research team that had developed a novel peptide drug that could potentially treat liver cancer...